A website to provide support for people who have or have had any type of cancer, for their caregivers and for their family members.
Results 1 to 6 of 6

Thread: Prostate cancer abbreviations

  1. #1
    Moderator Top User HighlanderCFH's Avatar
    Join Date
    Nov 2011
    Posts
    7,206

    Prostate cancer abbreviations

    PROSTATE CANCER ABBREVIATIONS

    COURTESY OF MICHAEL F
    NOTE: We're not sure what the asterisks mean.

    Djin has also recommended additional abbreviations, which can be found in alpha order within this fine list compiled by Michae F. --Chuck

    4K/4K score -- Non-biopsy test (uses 4 blood biomarkers)

    AAT*- androgen ablation therapy (same as ADT and HT)
    AAWR*– anti-androgen withdrawal response
    ADT*- androgen deprivation therapy (same as AAT and HT)
    ADT2 -*androgen deprivation therapy using two agents (typically the same as just ADT)
    ADT3*- triple androgen deprivation therapy (same as ADT but with the addition of finasteride/Proscar or dutasteride/Avodart)
    AS*– active surveillance
    AUS*- artificial urinary sphincter
    Adeno -- Adenocarcinoma
    BCR*- biochemical recurrance
    BPH*- benign prostatic hyperplasia (also hypertrophy)
    BPSA*- baseline PSA (used to mean an initial PSA value taken long before any risk of prostate cancer is suspected or a PSA value at the time of diagnosis)
    BL, B/L -- Bilateral
    BRACHY*- brachytherapy
    BS*- bone scan
    BT*- brachytherapy
    BX*- biopsy
    CAB*- complete androgen blockade (the combination of either surgical or medical castration with an antiandrogen like bicalutamide/Casodex)
    CADT*- continuous androgen deprivation therapy
    CaP*- cancer of the prostate
    CATH*- catheter
    CAT SCAN*- computerized axial tomography (same as CT scan)
    CHB*- combined hormone blockade (see also CAB, CHT, CHB2, CHT2)
    CHB2*- CHB with 2 medications (e.g., Lupron + Casodex)
    CHB3*- CHB with 3 medications (e.g. CHB2 + Proscar)
    CHBNDT*- CHB non-detectable [PSA] time
    CHEMO*- chemotherapy
    CHT*- combined hormonal therapy or treatment (see also CAB, CHB)
    CHTx3*or*CHT3*- see CHB3
    CIS*- cancer information service (of the National Cancer Institute)
    CP*- capsular penetration
    CRPC*– castration-resistant prostate cancer
    CRYO*- cryotherapy, cryoablation, cryosurgery
    CS*- clinical stage
    CT SCAN*- computerized tomography (also known as CAT scan or CT scan)*
    CXR – Chest X-ray
    DES*– diethylstilbestrol (an estrogen)
    DHEA*- dihydroepiandrosterone
    DHEA-S*- DHEA-sulfate
    DHT*- dihydrotestosterone
    DRE*- digital rectal examination
    DX*- diagnosis
    DXM*- dexamethasone (Decadron)
    EBR*- external beam radiation
    EBRT*- external beam radiation therapy
    ED*– erectile dysfunction
    ELISA*- enzyme-linked immunosorbent assay
    EPE*- extra prostatic extension
    EPO*- erythropoeitin (Procrit, Epogen)
    EXBT*- external beam therapy
    EXRT*- external radiation therapy
    FB = Forum Brother!
    FS = Forum Sister!
    g -- gram
    GG*- Gleason's grade
    GNRH*- gonadotropin-releasing hormone (see also LHRH)
    GP*- general practitioner
    Gray*- GY - an amount of radiation absorbed (One Gy = 100 rad)
    GS*- Gleason score
    GY -*Gray - an amount of radiation absorbed (One Gy = 100 rad)
    HA*- hormone ablation
    HB*- hormone blockade
    HDR*– high dose rate (usually pertains to brachytherapy
    HEM/ONC*– hematologic oncologist
    HIFU High-Intensity Focused Ultrasound
    HPF*- high powered field (under a microscope)
    HRPC*– hormone-refractory (or hormone-resistant) prostate cancer
    HT*- hormone therapy (same as AAT and ADT)
    Hx -- History
    IADT*– intermittent androgen deprivation therapy
    IAS*- intermittent androgen suppression
    IHT*– intermittent hormone therapy
    ICHT*- intermittent combined hormone therapy
    IGRT*– image guided radiation therapy
    IHT*- intermittent hormone therapy
    IMPT*- intensity modulated proton therapy
    IMRT*– intensity modulated radiation therapy
    LF*- laser fulguration (also: left side or flank)
    LHRH*- luteinizing hormone releasing hormone
    LNCaP*- cell line of human prostate cancer used in laboratory studies
    LRP*- laparoscopic radical prostatectomy
    M0-1*– Status of cancer metastasis, subset of staging
    MAB*- maximal androgen blockade (same as CAB)
    MAD*- maximal androgen deprivation (same as CAB)
    MO = MED/ONC*– medical oncologist
    MIP*- Molecular Imaging Program
    MRI*- magnetic resonance imaging
    N0-N3*- status of cancer in the lymph nodes (subset of staging)
    NDPSA*- non-detectable PSA
    NDX*- new diagnosis
    NEG*- negative
    NHB*- neoadjuvant hormone blockage
    NHT*- neoadjuvant hormone therapy
    ONC*- oncologist
    ORCH*- orchiectomy
    PBRT*- proton beam radiation therapy, or also, prostate bed radiation therapy
    PBT*- proton beam therapy
    PC*- prostate cancer
    PCa*- prostate cancer
    PCA3*- prostate cancer gene 3 (a genetic marker for prostate cancer), also used to mean a urine test designed to indentify the presence or absence of this genetic marker (properly “PCA3 test”)
    PET Scan*- Positron emission tomography scan
    PHI Prostate Health Index (uses three blood biomarkers)
    PIN*- prostatic intraepithelial (or intraductal) neoplasia
    PI-RADS -- Prostate Imaging Reporting and Data System -- refers to a structured reporting scheme for evaluating the prostate for prostate cancer [from radiopedia]
    PNI*- perineural invasion
    POS*- positive
    PP*- Partin prediction
    PPI*- post prostatectomy incontinence
    PRP*– see RPP
    PSA*- prostate specific antigen
    uPSA - ultrasensitive PSA assay
    PSA II*- prostate-specific antigen type II assay
    PSA RT-PCR*- PSA reverse transcriptase-polymerase chain reaction
    PSADT*- PSA doubling time
    PSAV*- PSA velocity
    PSM*- prostate specific membrane
    PSMA*- prostate specific membrane antigen
    PV*- prostate volume
    QCT*- quantitative computerized tomography (bone density scan)
    QOL*– quality of life
    RO = RAD/ONC*– radiation oncologist
    RALP*– robot-assisted laparoscopic prostatectomy (similar to LRP but with “robotic” assistance)
    RP*- radical prostatectomy
    RRP*- radical retropubic prostatectomy
    RT*- radiation therapy; also: right side
    SBRT*- stereotactic body radiation therapy
    SE*– side effects
    SEEDS*- brachytherapy
    SI*- seed implantation
    SM -- Surgical Margins
    SRT*- salvage radiation therapy
    SVI*- seminal vesicle invasion (or involvement)
    T*- testosterone, also tetraploid
    T0-T4*- status of cancer in the prostate itself (subset of staging)
    TAB*- total androgen blockade
    TFT*- targeted focal therapy*
    TNM or TNM classification -- tumor (T), nodes (N), and metastases (M). International system for the classification of cancerous tumor
    TRT*- testosterone replacement therapy*
    TRUS*- transrectal ultrasound
    TRUS-P*or*TRUSP*- transrectal ultrasound of the prostate*
    TTND*- time to non-detectable
    TURP,*TUR/P*- transurethral resection of the prostate
    TX*- treatment
    TZ*- transition zone (of prostate)
    URO*- urologist
    US*- ultrasound
    UTI*- urinary tract infection
    UTI*- urinary track infection
    WBC*- white blood cell count
    WBC/HPF*- white blood cells counted per high powered field (of a microscope.)
    WD*- well differentiated
    WPRT*- whole pelvic radiation therapy
    WW*- watchful waiting
    XRT*- external radiation therapy
    Last edited by HighlanderCFH; 10-09-2017 at 05:26 AM. Reason: Additional Abbreviations Entered
    July 2011 local PSA lab reading 6.41 (from 4.1 in 2009). Mayo Clinic PSA 9/ 2011 = 5.7.
    Local uro DRE revealed significant BPH, no lumps.
    PCa Dx Aug. 2011 age of 61.
    Biopsy DXd adenocarcinoma in 3/20 cores (one 5%, two 20%). T2C.
    Gleason 3+3=6. CT abdomen, bone scan negative.
    DaVinci prostatectomy 11/1/11 at Mayo Clinic (Rochester, MN), nerve sparing, age 62.
    Surgeon was Dr. Matthew Tollefson, who I highly recommend.
    Final pathology shows tumor confined to prostate.
    5 lymph nodes, seminal vesicules, extraprostatic soft tissue all negative.
    1.0 x 0.6 x 0.6 cm mass involving right posterior inferior, right posterior apex & left
    mid posterior prostate. Right posterior apex margin involved by tumor over 0.2 cm length,
    doctor says this is insignificant.
    Prostate 98 grams, tumor 2 grams.
    Catheter out in 7 days. No incontinence, minor dripping for a few weeks.
    Seven annual post-op exams 2012 through 2018: PSA <0.1
    Semi-firm erections without "training wheels," usable erections with 100mg Sildenafil.
    NOTE: ED caused by BPH, not the surgery.

  2. #2
    Senior User
    Join Date
    Dec 2014
    Posts
    232
    That was a lot of work, Michael F. Thank you!
    Age 70, ( now 73 ) consistent low psa till now, dre's are very important as this got way ahead of me without them!
    PSA rise 3.8 to 4.3 ( 10/2014 )
    No family history, one of eleven siblings.
    Biopsy 11/20/14 Gleason 9 with 5+4, T2c score
    9 or 10 of 12 positive 12/04/14
    Cat scan, bone scan, m r i show confined to prostate gland
    Two weeks intensive research....HT and radiation decision made
    First HT 12/16/14 lots of side effects ( Degarelix ) (3/11 pain and bruising at injection site, sleep issues, sweats and maybe some dark thoughts)
    Second HT 1/13 no side effects ( Eligard )( much easier than the 30 day, no pain or bruising, only sweats and sleep issues )
    Cat scan and tattoos 3/6/15 Dry run 3/18 actual radiation on 3/19
    Wrapped up the radiation on 5/22 and met the Memorial Day goal!
    Second six month Eligard on 7/14/15. If follow up PSA test goes well may opt out.
    .01 PSA at 90 day follow up, opted out of h t after a year. Still undetectable after three years.

  3. #3
    Experienced User
    Join Date
    Mar 2017
    Posts
    71
    WOW...a LOT more then I was expecting! thanks!
    Age (at diagnosis):59
    Family history: Father Dx PC ~ age 60 brachytherapy; colon cancer surgery ~age 70 (deceased heart failure ~ age 80); Brother age 67, PSAs low (<2)
    June 2013 PSA: 4.20 DRE: Normal
    Nov 2015 PSA: 5.51 DRE: GP noted smooth, slight enlargement. Biopsy suggested.
    Mar 2016 Biopsy: 2/12 cores positive; G3+3
    Nov 2016 PSA: 8.76
    Dec 2016 Biopsy: 1/12 core positive right lateral apex; G5+3
    3/08/17 daVinci RALP; Pathology: 34 grams, tumor present 13/37 cassettes, Margins involved 4mm distance 6:00-9:00 apex margin; G4+3, stage pT2c; Extraprostatic extension, seminal vesicle, 11 lymph nodes (7R, 4L) all negative
    Cystograms 3/23 and 3/30 suggested small leak, speculated probably contrast agent in bulbourethral duct
    3/30/17 Catheter out (22 day!)
    4/29/17 Ran/walked half marathon in 2hr 39 mins!
    Post Surg PSA: Jun/17 0.01 Sep/17 0.00 Dec/17 0.02 Mar/18 0.01 Sep/18 0.01 Mar/19 0.00

  4. #4
    Newbie New User
    Join Date
    Mar 2018
    Posts
    1
    WOW!

    Much appreciated - thank you!

  5. #5
    Experienced User
    Join Date
    Oct 2018
    Posts
    94
    This is great, especially for a newcomer like me. Thanks muchly, Highlander.
    Born 1953. All care at Kaiser in LA.

    10/11/18: 2 pos G6 cores of 12. Pros vol 33g.
    12/6/18: MRI finds 15.5mm diameter mass, labeled PI-RADS 5.
    1/4/19: G6 tumor 10% in 1 of 6 cores; uro recs treatment
    2/27/19: Dr. Epstein - G6 on that single guided core; 20%
    3/26/19: Color Doppler with Dr. Bahn; recs AS.
    5/6/19: 2nd Kaiser uro recs AS.
    6/7/19: Dr. Clayton Lau at City of Hope recs AS.
    7/8/19: 3rd Kaiser uro: AS.
    7/15/19: Dr. Leonard Marks at UCLA: AS. UCLA rad finds nothing abnormal in MRI.
    8/23/19: Another Kaiser rad finds nothing abnormal.
    Changing docs to 3rd uro.

    PSA
    8/2/18: 1.2
    3/26/19: 1.8
    6/14/19: 2.2

  6. #6
    Moderator Top User HighlanderCFH's Avatar
    Join Date
    Nov 2011
    Posts
    7,206
    You're muchly welcome, my friend!
    July 2011 local PSA lab reading 6.41 (from 4.1 in 2009). Mayo Clinic PSA 9/ 2011 = 5.7.
    Local uro DRE revealed significant BPH, no lumps.
    PCa Dx Aug. 2011 age of 61.
    Biopsy DXd adenocarcinoma in 3/20 cores (one 5%, two 20%). T2C.
    Gleason 3+3=6. CT abdomen, bone scan negative.
    DaVinci prostatectomy 11/1/11 at Mayo Clinic (Rochester, MN), nerve sparing, age 62.
    Surgeon was Dr. Matthew Tollefson, who I highly recommend.
    Final pathology shows tumor confined to prostate.
    5 lymph nodes, seminal vesicules, extraprostatic soft tissue all negative.
    1.0 x 0.6 x 0.6 cm mass involving right posterior inferior, right posterior apex & left
    mid posterior prostate. Right posterior apex margin involved by tumor over 0.2 cm length,
    doctor says this is insignificant.
    Prostate 98 grams, tumor 2 grams.
    Catheter out in 7 days. No incontinence, minor dripping for a few weeks.
    Seven annual post-op exams 2012 through 2018: PSA <0.1
    Semi-firm erections without "training wheels," usable erections with 100mg Sildenafil.
    NOTE: ED caused by BPH, not the surgery.

 

Similar Threads

  1. Replies: 17
    Last Post: 05-23-2017, 04:37 PM
  2. Replies: 3
    Last Post: 05-01-2014, 09:51 PM
  3. Recurrent prostate cancer after prostate removal
    By Anthony Ryan in forum Prostate Cancer Forum
    Replies: 11
    Last Post: 12-30-2012, 09:33 AM
  4. Quiestions for post surgery prostate cancer treatment (prostate removal)
    By Larry_Walker in forum Prostate Cancer Forum
    Replies: 4
    Last Post: 10-18-2011, 11:38 PM
  5. AVOID INTERNET ABBREVIATIONS
    By brainman in forum Forum Policies
    Replies: 0
    Last Post: 07-12-2007, 03:30 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •